Erlotinib for the treatment of relapsed non-small cell lung cancer.
McLeod C, Bagust A, Boland A, Hockenhull J, Dundar Y, Proudlove C, Davis H, Green J, Macbeth F, Stevenson J, Walley T, Dickson R.
McLeod C, et al.
Health Technol Assess. 2009 Jun;13 Suppl 1:41-7. doi: 10.3310/hta13suppl1/07.
Health Technol Assess. 2009.
PMID: 19567213
Free article.